BioCentury
ARTICLE | Company News

Dnavec, Sumitomo Dainippon deal

November 10, 2014 8:00 AM UTC

The Dnavec Corp. subsidiary of I'rom granted Sumitomo Dainippon a license to a patent covering technology to produce clinical induced pluripotent stem (iPS) cells for use in human regenerative medicin...